Navigation Links
Listing on Frankfurt Stock Exchange for CTI (

LOS ANGELES, Nov. 3, 2010 /PRNewswire/ -- CTI (OTC Bulletin Board: CVAT, Berlin & Stuttgart: WTC) proudly announces that its common shares are now also listed on the Frankfurt Stock Exchange under the ticket symbol WTC.

CTI's CEO Roman Gordon stated: "We hope to achieve another milestone with the listing on the Frankfurt Stock Exchange to help with our long term focus...this listing should help us gain visibility and support in the European market.  The listing on the Frankfurt exchange will increase the profile of CTI with both private and institutional investors in Germany and across Europe.  This opportunity to broaden our shareholder base comes at an excellent time for our company as we move into the next phase of our corporate initiative."

Mike Gorodnitsky, President of CTI added: "European investors have a strong interest for investing in 'Green-Tech' companies.  Particularly our relationship with Desmet Ballestra (, a large conglomerate with its headquarters in Europe, specializing in the engineering and refining processes for edible and other oils will help expose and introduce our technology throughout the world."

Next to trading in the U.S., and the German exchanges in Berlin and Stuttgart, the Frankfurt Stock Exchange may help CTI build a better investor foundation to move forward.  The Frankfurt Stock Exchange provides full-service trading capabilities, which include a trading floor as well as an electronic trading exchange, XETRA.

About the Frankfurt Stock Exchange

The Frankfurt Stock Exchange, known as the Frankfurter Wertpapierenboerse (FWB) is one of the world's largest trading centers for securities.  Operated by the Deutsche Boerse AG, FWB is the largest of the eight Germany stock exchanges.  The Deutsche Boerse's products and services portfolio cover the entire process chain including securities and derivatives trading, transaction settlement, the provision of market information, as well as the development and operation of electronic trading systems.  For more information, visit the Deutsche Boerse at:

About CTI:

CTI is a "Green-Tech" company, established in 2006.  CTI designs and engineers NANO technology based skid systems that are designed to serve growing markets such as edible oil refining, renewable fuels, crude oil yield enhancement, water-fuel emulsions, water purification and algae oil extraction.  R&D has led to products including the Green D+Plus NANO Neutralization System - a vegetable oil refining system, and the Bioforce 9000 NANO Reactor System which performs the transeseterification process during the production of biodiesel.  Both the Green D+Plus System and the Bioforce 9000 NANO Reactor System employ our proprietary, continuous flow-through, hydrodynamic NANO Technology in the form of our multi-stage NANO Serier of reactors.  The Green D+ Plus System is currently in commercial operation at Carolina Soya, LLC, a vegetable oil refining facility located in South Carolina.  Paul E. Hankey Jr, General Manager of Carolina Soya recently stated: "The operation of the Green D+ Plus Nano Refining System has been straightforward and simple...and will continue to be a significant process improvement for our refinery."  For additional information please visit:

Safe Harbor: Pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995, and within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Exchange Act of 1934, any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals and assumptions of future events or performance are not statements of historical fact and may be "forward-looking statements."  Forward-looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated.  Forward-looking statements in this release may be identified through the use of words such as "expects," "will," "anticipates," "estimates," "believes," or statements indicating certain actions such as "may," "could," or "might" occur.  Such statements reflect the current views of CTI with respect to future events and are subject to certain assumptions, including those described in this release.  These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products, services, and technologies, competitive market conditions, successful integration of acquisitions, the ability to secure additional sources of financing, the ability to reduce operating expenses and other factors.  The actual results that the Company achieves may differ materially from any forward-looking statements due to such risks and uncertainties.  Cavitation Technologies, Inc. does not undertake any responsibility to update the "forward-looking" statements contained in this news release.

Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Oncothyreon announces receipt of notice of non-compliance with market value of listed securities standard for listing on The NASDAQ Global Market
2. Oncothyreon announces receipt of NASDAQ letter regarding compliance with NASDAQ Global Market listing standards
3. PLC Systems Receives Delisting Notice From American Stock Exchange
4. EntreMed Announces Stock Listing Transfer to Nasdaq Capital Market
5. Nasdaq Grants VirtualScopics Request for Continued Listing
6. Memory Pharmaceuticals Provides Update on NASDAQ Listing Status
7. Memory Pharmaceuticals Granted Extension to Comply with NASDAQ Listing Requirements
8. Spherix Transfers Stock Listing to Nasdaq Capital Market
9. NYSE Alternext US Accepts China Shenghuos Compliance Plan for Continued Listing
10. Interleukin Genetics Receives Notification of Failure to Meet Continued Listing Standard Section 1003(a)(iii)
11. BioSpecifics Technologies Corp. Announces Listing on NASDAQ Global Market
Post Your Comments:
(Date:6/24/2016)... , ... June 24, 2016 , ... While the majority ... as the Cary 5000 and the 6000i models are higher end machines that use ... height of the spectrophotometer’s light beam from the bottom of the cuvette holder. ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... the release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” ... and retention in this eBook by providing practical tips, tools, and strategies for ...
(Date:6/23/2016)...   Boston Biomedical , an industry leader ... target cancer stemness pathways, announced that its lead ... Designation from the U.S. Food and Drug Administration ... gastroesophageal junction (GEJ) cancer. Napabucasin is an orally ... stemness pathways by targeting STAT3, and is currently ...
(Date:6/23/2016)... 23, 2016 A person commits a crime, and ... to track the criminal down. An outbreak of ... Drug Administration (FDA) uses DNA evidence to track down the ... Sound far-fetched? It,s not. The FDA has increasingly used a ... of foodborne illnesses. Put as simply as possible, whole genome ...
Breaking Biology Technology:
(Date:6/1/2016)... , June 1, 2016 Favorable ... Election Administration and Criminal Identification to Boost Global Biometrics ... recently released TechSci Research report, " Global Biometrics Market ... Competition Forecast and Opportunities, 2011 - 2021", the global ... by 2021, on account of growing security concerns across ...
(Date:5/12/2016)... -- , a brand of Troubadour Research ... the Q1 wave of its quarterly wearables survey. A ... to a program where they would receive discounts for ... "We were surprised to see that so ... , CEO of Troubadour Research, "primarily because there are ...
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
Breaking Biology News(10 mins):